Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
95% CI
absence
addition
administration of hydroxychloroquine
Admission
aerosol-generating procedures
allergy
analyzed
Anesthesia
antibody
approved
ARMS
assigned
balanced randomization
blind
Cancer
Cantabria
carried
CDC
Cell
Chemoprophylaxis
clinical
Clinical data
clinically
coated
Committee
comparator
Comparator group
computer-generated
control group
Controlled
Controlled clinical trial
Controlled trial
coronavirus
COVID
COVID-19
criteria
CURB
current
detect
Determination
disease
dissemination
double blind
double-blind
dropout rate
Efficacy
Efficacy and safety
element
ELISA kit
Emergency
Endocrine
estimate
Ethics
Euroimmun
Evidence
evidence of
Germany
GRADE
greater
group
Health
Health authority
health-care
healthcare personnel
Healthcare professional
healthcare professionals
heart
heart failure
help
hematological
high risk
hospital
Hydroxychloroquine
hydroxychloroquine sulfate
hygiene
Hypothesis
ICU
IDT
IgA
IgG
IgM and IgG
immune
immunodeficiency
in vitro
incidence
include
Infection
inhibit
intensive care unit
Intervention
investigator
kidney
lactation
liver
measure
Measures
Medicine
Negative PCR
neurological
New York
number
observation period
outcome
participant
PCR
performed
Personal protective equipment
Placebo
positive
positive SARS-CoV-2 PCR
positive serology
Pregnancy
presenting
Prevalence
Primary outcome
probes
product
professional
Prophylaxis
Prospective
PROTECT
Protective
protocol
Psychiatric
randomised
randomised controlled trial
randomization
Randomized
randomized trial
RCT
receive
recruitment
reduce
reported
responsible
risk
RT-PCR
Sample size
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 PCR
sequence
Seroconversion
serological
serology
severity
Significant
single center
single-center study
social distancing
Spain
Spanish
Standard
Statistical power
status
Study protocol
subject
Support
Symptom
symptomatic and asymptomatic
Tablet
Takara
Taking
Tamoxifen
Transmission
Treatment
two-tailed
university
Vaccine
virus
website
while
[DOI] 10.1186/s13063-020-04400-4 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04400-4 PMC 바로가기 [Article Type] Letter